求助7篇文献 不胜感激

aaaszw

& D1 s" F* T7 g, v  r2 a6 [# f
6 h! T! X# v6 o5 p- h6 m
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.
9 R) O: Y: n: m7 c# ^/ |$ Ahttps://www.ncbi.nlm.nih.gov/pubmed/27912061
. U" W: F9 E; ~4 I
! U0 z; h: P; B8 G4 z9 VThe long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.
2 X2 U* m& y* H/ `3 jhttps://www.ncbi.nlm.nih.gov/pubmed/27525555
6 I/ p* q% H. h4 w1 e6 `# D
5 t) D$ p9 t- i$ TBioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion
" C. v  p2 _9 W8 J- Zhttps://www.ncbi.nlm.nih.gov/pubmed/27496729
  q, C( v& |/ i  H
1 z; K# ?5 K. MCutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.
4 e! K0 ?4 J* E8 `) N7 _$ C' {6 Lhttps://www.ncbi.nlm.nih.gov/pubmed/274307225 s2 S8 `% n8 {# |% d
0 }- b8 e0 K$ N, M4 q* h0 i& |
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.
4 Z) N( c' y( R+ G9 Fhttps://www.ncbi.nlm.nih.gov/pubmed/27192569
8 T! W. {1 ^* ]5 P( ~+ w
6 T( i  m; q: A; r7 A3 H" q) kCombination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling& y, m9 h- @& b+ J/ _, l3 x* y. t
https://www.ncbi.nlm.nih.gov/pubmed/27058661
3 s) b1 w' [6 n3 N7 ]6 M3 ]
. c1 C; W/ v$ e) G( eDe-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute
+ P; F6 o( ]2 c+ z& u6 vhttps://www.ncbi.nlm.nih.gov/pubmed/27036972

aaaszw

回复 lchanlon 的帖子
: m* u3 T* @3 m0 V( a% g' f9 L- Z
: C5 p+ g5 b7 e% M: M6 Emerci beaucoup ：）